Last viewed: ABBV


Prices are updated after-hours



nyse:ABBV AbbVie Inc.

ABBV | $133.355 | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (1.2% 1m) (18.9% 1y) (-1.3% 2d) (-2.3% 3d) (-1.0% 7d) (NaN% volume)
http://www.abbvie.com
Sec Filling | Patents | 30000 employees

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Drugs
Alcohol - Hand Sanitizer (Alcohol)
Androgel (Testosterone)
Creon (Pancrelipase)
Depakote (Divalproex Sodium)
Depakote ER (Divalproex Sodium)
Depakote Sprinkles (Divalproex Sodium)
Duopa (Carbidopa and Levodopa)
Gengraf (Cyclosporine)
Humira (Adalimumab)
Kaletra (Lopinavir and Ritonavir)
K-Tab (Potassium Chloride)
Lupaneta Pack (leuprolide acetate and norethindrone acetate)
Lupron Depot (leuprolide acetate)
Lupron Depot-PED (leuprolide acetate)
Marinol (Dronabinol)
Mavyret (Glecaprevir and Pibrentasvir)
Niaspan (Niacin)
Nimbex (Cisatracurium besylate)
Norvir (Ritonavir)
Oriahnn (Elagolix and Estradiol and Norethisterone)
Orilissa (Elagolix)
Rinvoq (Upadacitinib)
Skyrizi (Risankizumab-rzaa)
Survanta (Beractant)
Synthroid (Levothyroxine Sodium)
Tarka (Trandolapril and Verapamil Hydrochloride)
Tricor (Fenofibrate)
Trilipix (Fenofibric Acid)
Ultane (Sevoflurane)
Venclexta (Venetoclax)
Viekira Pak (Dasabuvir and Ombitasvir and Paritaprevir and Ritonavir)
Zemplar (Paricalcitol)

add to today's watch list email alert is off




cancer   hiv   autoimmunity   hepatitis   fibrosis   metabolic   parkinson   neurological  

Press-releases


U.S. FDA Approves RINVOQ® (upadacitinib) to Treat Adults and Children 12 Years and Older with Refractory, Moderate to Severe Atopic Dermatitis
Published: 2022-01-14 (Crawled : 19:00) - prnewswire.com
ABBV | $133.355 | twitter stocktwits trandingview |
Health Technology

rinvoq fda atopic dermatitis dermatitis era children
Technavio Forecasts Intrauterine Contraceptive Devices Market to grow by USD 799.85 million from 2020 to 2025
Published: 2022-01-13 (Crawled : 11:00) - prnewswire.com
ABLZF | $39.74 | twitter stocktwits trandingview |
Producer Manufacturing
| | O: -0.93% H: 0.91% C: 0.86%
ABB | $37.305 | twitter stocktwits trandingview |
Producer Manufacturing
| | O: 0.03% H: 0.0% C: 0.0%
ABBV | $133.355 | twitter stocktwits trandingview |
Health Technology
| | O: -1.08% H: 0.0% C: 0.0%

trace ces device
AbbVie Confirms Guidance of Greater Than $15 Billion in Combined Risk-Adjusted Sales for Rinvoq and Skyrizi in 2025
Published: 2022-01-11 (Crawled : 14:30) - biospace.com/
ABBV | $133.355 | twitter stocktwits trandingview |
Health Technology
| | O: 0.81% H: 0.0% C: 0.0%


ACELYRIN Appoints Melanie Gloria as Chief Operating Officer
Published: 2022-01-11 (Crawled : 13:00) - biospace.com/
ABBV | $133.355 | twitter stocktwits trandingview |
Health Technology
| | O: 0.81% H: 0.0% C: 0.0%
ABT | News | $130.53 | twitter stocktwits trandingview |
Health Technology
| | O: -0.22% H: 0.0% C: 0.0%


Ironwood Pharmaceuticals Provides Update on FY 2021 Financial Guidance and Announces FY 2022 Financial Guidance
Published: 2022-01-10 (Crawled : 13:30) - biospace.com/
IRWD | $11.72 | twitter stocktwits trandingview |
Health Technology
| | O: -3.79% H: 4.65% C: 4.29%
ABBV | $133.355 | twitter stocktwits trandingview |
Health Technology
| | O: -0.37% H: 0.0% C: 0.0%


4 EV Charging Stocks to Buy Ahead of Biden’s National Network
Published: 2022-01-06 (Crawled : 20:00) - beamforall.com
ABBV | $133.355 | twitter stocktwits trandingview |
Health Technology
| | O: -0.01% H: 0.0% C: 0.0%
BEEM | $14.35 | twitter stocktwits trandingview |
Utilities
| | O: 0.0% H: 3.72% C: -2.88%
GOOGL | $2737.965 | twitter stocktwits trandingview |
Technology Services
| | O: 0.29% H: 0.22% C: -0.82%

charging work
Aspira Women’s Health Announces Fourth Quarter Operational Metrics and Provides Updates on Its OvaWatch and EndoCheck Programs
Published: 2022-01-05 (Crawled : 12:30) - vermillion.com
ABBV | $133.355 | twitter stocktwits trandingview |
Health Technology
| | O: -0.01% H: 0.0% C: 0.0%
AWH | $1.33 | twitter stocktwits trandingview |
Health Technology
| | O: 2.34% H: 5.71% C: -8.57%

health ces era women
AbbVie to Host Fourth-Quarter and Full-Year 2021 Earnings Conference Call
Published: 2022-01-05 (Crawled : 15:30) - biospace.com/
ABBV | $133.355 | twitter stocktwits trandingview |
Health Technology
| | O: -0.01% H: 0.0% C: 0.0%

conference
FDA Accepts Samsung Bioepis’ and Organon’s sBLA for their Citrate-Free, High-Concentration HUMIRA® (Adalimumab) Biosimilar Candidate
Published: 2022-01-05 (Crawled : 16:00) - biospace.com/
MRK | $81.38 | twitter stocktwits trandingview |
Health Technology
| | O: 0.32% H: 3.3% C: 2.1%
ABBV | $133.355 | twitter stocktwits trandingview |
Health Technology
| | O: -0.01% H: 0.0% C: 0.0%

humira fda
Global Alzheimer's Disease Therapeutics Market Projected To Generate Revenue Of $9.97 Billion By 2028
Published: 2022-01-04 (Crawled : 14:00) - prnewswire.com
SNY | News | $51.51 | twitter stocktwits trandingview |
Health Technology
| | O: -2.03% H: 0.0% C: 0.0%
ABBV | $133.355 | twitter stocktwits trandingview |
Health Technology
| | O: -0.04% H: 0.0% C: 0.0%
REGN | $615.24 | twitter stocktwits trandingview |
Health Technology
| | O: -0.44% H: 0.0% C: 0.0%
HOTH | $0.8101 | twitter stocktwits trandingview |
Health Technology
| | O: 61.79% H: 53.51% C: 14.04%
SAVA | $45.88 | twitter stocktwits trandingview |
Health Technology
| | O: 1.61% H: 2.11% C: -1.07%

alzheimer era therapeutics disease
See all


Last 15 days Sec forms
File Id Form Date Direction Code Amount Transacted Owned Amount
0001179110-21-008720 4 2021-09-10 Buy G 30000 78500
0001179110-21-008720 4 2021-09-10 Sell G 30000 18711


Your Today's Watch List
Sign in to create a watchlist
Today's Insiders Buying

Yesterday's Insiders Buying